Krystal Biotech Files Q1 2025 10-Q Report
Ticker: KRYS · Form: 10-Q · Filed: May 6, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, quarterly-report
TL;DR
Krystal Biotech's Q1 2025 10-Q is in. Check financials.
AI Summary
Krystal Biotech, Inc. filed its quarterly report for the period ending March 31, 2025. The company, based in Pittsburgh, PA, is involved in the biological products industry. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with an update on Krystal Biotech's financial health and operational performance during the first quarter of 2025, crucial for assessing the company's trajectory.
Risk Assessment
Risk Level: medium — As a biotech company, Krystal Biotech faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-05-06 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Krystal Biotech, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250506 (date) — Filing date of the report
- Pittsburgh, PA (location) — Company's business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q report filed with the SEC?
This 10-Q report was filed with the SEC on May 6, 2025.
What is the primary business of Krystal Biotech, Inc.?
Krystal Biotech, Inc. is primarily involved in the biological products industry, specifically focusing on biological products (no diagnostic substances).
Where is Krystal Biotech, Inc. located?
Krystal Biotech, Inc. is located in Pittsburgh, PA, with its business and mailing address at 2100 Wharton Street, Suite 701.
What fiscal year end does Krystal Biotech, Inc. observe?
Krystal Biotech, Inc. observes a fiscal year end on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Krystal Biotech, Inc. (KRYS).